Written by Admin | May 20, 2020
Aetion has partnered with the Food and Drug Administration (FDA) to utilize real-world data (RWD) for understanding and responding to COVID-19. The collaboration aims to assess and analyze real-world datasets using the Aetion® Evidence Platform to gain insights into the course, treatment, diagnostic patterns, and risk factors related to COVID-19.
Read More